Please Wait.....
Report
Global Cell Therapy Market Forecast 2022-2030
Market Report I 2022-10-24 I 228 Pages I Inkwood Research
KEY FINDINGS
The global cell therapy market is projected to register a CAGR of 14.46% during the forecast period, 2022-2030. The market growth is accredited to the increasing prevalence of chronic disease, thriving regenerative medicine, and rising cellular therapy clinical trials.
MARKET INSIGHTS
Cell therapy has a vast range of applications in offering diagnostic/prognostic information during clinical research related to several infectious diseases, cancer, and HIV/AIDS. Also, several factors like the growing population, climate change, and the growing contact between animals and humans have raised the threat of virus outbreaks. Cell therapy replaces dysfunctional or diseased cells with healthy functioning ones. The cells majorly used for such advanced therapies are stem cells, given their ability to differentiate into specific cells needed for repairing defective cells.
Further, cell therapy has applications in the development of regenerative medicine. Additionally, cells like bone marrow and blood cells, embryonic stem cells, adult stem cells, and solid & immature cells are used in cell therapy procedures. Such factors drive the global cell therapy market growth. However, the growing skills gap restricts market growth.
REGIONAL INSIGHTS
The global cell therapy market's geographical segmentation includes the assessment of Asia-Pacific, Europe, North America, and Rest of World. North America is the largest revenue-generating region in the global market, supplemented by the presence of key players, advanced healthcare infrastructure, robust reimbursement policies, extensive research and development, etc.
COMPETITIVE INSIGHTS
Some of the eminent companies operating in the market include Bristol Myers Squibb Company, Gilead Sciences Inc, Cells for Cells SA, JCR Pharmaceuticals Co Ltd, Anterogen Co Ltd, etc.
Our report offerings include:
- Explore key findings of the overall market
- Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
- Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
- Market Segmentation cater to a thorough assessment of key segments with their market estimations
- Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
- Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
- Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
- Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. INCREASING CELLULAR THERAPY CLINICAL TRIALS
3.1.2. GROWTH OF REGENERATIVE MEDICINE
3.1.3. HIGH PREVALENCE OF CHRONIC DISEASES
3.2. KEY RESTRAINTS
3.2.1. INCREASING SKILLS GAP
3.2.2. HIGH COSTS
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON CELL THERAPY MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER'S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. REGULATORY FRAMEWORK
4.5. OPPORTUNITY MATRIX
4.6. VENDOR LANDSCAPE
5. MARKET BY CELL TYPE
5.1. STEM CELL
5.1.1. BONE MARROW
5.1.2. BLOOD
5.1.3. UMBILICAL CORD-DERIVED STEM CELL
5.1.4. ADIPOSE-DERIVED STEM CELL
5.1.5. OTHERS
5.2. NON-STEM CELL
6. MARKET BY THERAPY TYPE
6.1. AUTOLOGOUS
6.2. ALLOGENEIC
7. MARKET BY THERAPEUTIC APPLICATION
7.1. MALIGNANCIES
7.2. MUSCULOSKELETAL DISORDERS
7.3. AUTOIMMUNE DISORDERS
7.4. DERMATOLOGY
7.5. OTHER APPLICATIONS
8. MARKET BY END-USER
8.1. HOSPITALS & CLINICS
8.2. ACADEMIC & RESEARCH INSTITUTES
9. GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1. MARKET SIZE & ESTIMATES
9.1.2. KEY DRIVERS
9.1.3. KEY CHALLENGES
9.1.4. KEY PLAYERS
9.1.5. COUNTRY ANALYSIS
9.1.5.1. UNITED STATES
9.1.5.2. CANADA
9.2. EUROPE
9.2.1. MARKET SIZE & ESTIMATES
9.2.2. KEY DRIVERS
9.2.3. KEY CHALLENGES
9.2.4. KEY PLAYERS
9.2.5. COUNTRY ANALYSIS
9.2.5.1. UNITED KINGDOM
9.2.5.2. GERMANY
9.2.5.3. FRANCE
9.2.5.4. ITALY
9.2.5.5. SPAIN
9.2.5.6. BELGIUM
9.2.5.7. POLAND
9.2.5.8. REST OF EUROPE
9.3. ASIA-PACIFIC
9.3.1. MARKET SIZE & ESTIMATES
9.3.2. KEY DRIVERS
9.3.3. KEY CHALLENGES
9.3.4. KEY PLAYERS
9.3.5. COUNTRY ANALYSIS
9.3.5.1. CHINA
9.3.5.2. JAPAN
9.3.5.3. INDIA
9.3.5.4. SOUTH KOREA
9.3.5.5. THAILAND
9.3.5.6. SINGAPORE
9.3.5.7. AUSTRALIA & NEW ZEALAND
9.3.5.8. REST OF ASIA-PACIFIC
9.4. REST OF WORLD
9.4.1. MARKET SIZE & ESTIMATES
9.4.2. KEY DRIVERS
9.4.3. KEY CHALLENGES
9.4.4. KEY PLAYERS
9.4.5. REGIONAL ANALYSIS
9.4.5.1. LATIN AMERICA
9.4.5.2. MIDDLE EAST & AFRICA
10. COMPETITIVE LANDSCAPE
10.1. KEY STRATEGIC DEVELOPMENTS
10.1.1. MERGERS & ACQUISITIONS
10.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
10.1.3. PARTNERSHIPS & AGREEMENTS
10.1.4. BUSINESS EXPANSIONS
10.2. COMPANY PROFILES
10.2.1. ANTEROGEN CO LTD
10.2.2. BRISTOL MYERS SQUIBB COMPANY
10.2.3. CELLS FOR CELLS SA
10.2.4. GILEAD SCIENCES INC
10.2.5. JCR PHARMACEUTICALS CO LTD
10.2.6. KOLON TISSUEGENE INC
10.2.7. MEDIPOST CO LTD
10.2.8. MESOBLAST LIMITED
10.2.9. NUVASIVE INC
10.2.10. SMITH & NEPHEW PLC
10.2.11. STEMEDICA CELL TECHNOLOGIES INC
10.2.12. VERICEL CORPORATION
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - CELL THERAPY
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: GLOBAL CELL THERAPY MARKET, BY CELL TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 4: GLOBAL CELL THERAPY MARKET, BY CELL TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 5: GLOBAL STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 6: GLOBAL STEM CELL MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 7: GLOBAL CELL THERAPY MARKET, BY STEM CELL, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 8: GLOBAL CELL THERAPY MARKET, BY STEM CELL, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 9: GLOBAL BONE MARROW MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 10: GLOBAL BONE MARROW MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 11: GLOBAL BLOOD MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 12: GLOBAL BLOOD MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 13: GLOBAL UMBILICAL CORD-DERIVED STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 14: GLOBAL UMBILICAL CORD-DERIVED STEM CELL MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 15: GLOBAL ADIPOSE-DERIVED STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 16: GLOBAL ADIPOSE-DERIVED STEM CELL MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 17: GLOBAL OTHERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 18: GLOBAL OTHERS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 19: GLOBAL NON-STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 20: GLOBAL NON-STEM CELL MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 21: GLOBAL CELL THERAPY MARKET, BY THERAPY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 22: GLOBAL CELL THERAPY MARKET, BY THERAPY TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 23: GLOBAL AUTOLOGOUS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 24: GLOBAL AUTOLOGOUS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 25: GLOBAL ALLOGENEIC MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 26: GLOBAL ALLOGENEIC MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 27: GLOBAL CELL THERAPY MARKET, BY THERAPEUTIC APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 28: GLOBAL CELL THERAPY MARKET, BY THERAPEUTIC APPLICATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 29: GLOBAL MALIGNANCIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 30: GLOBAL MALIGNANCIES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 31: GLOBAL MUSCULOSKELETAL DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 32: GLOBAL MUSCULOSKELETAL DISORDERS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 33: GLOBAL AUTOIMMUNE DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 34: GLOBAL AUTOIMMUNE DISORDERS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 35: GLOBAL DERMATOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 36: GLOBAL DERMATOLOGY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 37: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 38: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 39: GLOBAL CELL THERAPY MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 40: GLOBAL CELL THERAPY MARKET, BY END-USER, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 41: GLOBAL HOSPITALS & CLINICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 42: GLOBAL HOSPITALS & CLINICS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 43: GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 44: GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 45: GLOBAL CELL THERAPY MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 46: GLOBAL CELL THERAPY MARKET, BY GEOGRAPHY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 47: NORTH AMERICA CELL THERAPY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 48: NORTH AMERICA CELL THERAPY MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 49: KEY PLAYERS IN NORTH AMERICA CELL THERAPY MARKET
TABLE 50: LIST FDA-APPROVED CELL THERAPY PRODUCTS
TABLE 51: EUROPE CELL THERAPY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 52: EUROPE CELL THERAPY MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 53: KEY PLAYERS IN EUROPE CELL THERAPY MARKET
TABLE 54: ASIA-PACIFIC CELL THERAPY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 55: ASIA-PACIFIC CELL THERAPY MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 56: KEY PLAYERS IN ASIA-PACIFIC CELL THERAPY MARKET
TABLE 57: REST OF WORLD CELL THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 58: REST OF WORLD CELL THERAPY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 59: KEY PLAYERS IN REST OF WORLD CELL THERAPY MARKET
TABLE 60: LIST OF MERGERS & ACQUISITIONS
TABLE 61: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 62: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 63: LIST OF BUSINESS EXPANSIONS
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: GLOBAL CELL THERAPY MARKET, GROWTH POTENTIAL, BY CELL TYPE, IN 2021
FIGURE 6: GLOBAL CELL THERAPY MARKET, BY STEM CELL, 2022-2030 (IN $ MILLION)
FIGURE 7: GLOBAL CELL THERAPY MARKET, GROWTH POTENTIAL, BY STEM CELL, IN 2021
FIGURE 8: GLOBAL CELL THERAPY MARKET, BY BONE MARROW, 2022-2030 (IN $ MILLION)
FIGURE 9: GLOBAL CELL THERAPY MARKET, BY BLOOD, 2022-2030 (IN $ MILLION)
FIGURE 10: GLOBAL CELL THERAPY MARKET, BY UMBILICAL CORD-DERIVED STEM CELL, 2022-2030 (IN $ MILLION)
FIGURE 11: GLOBAL CELL THERAPY MARKET, BY ADIPOSE-DERIVED STEM CELL, 2022-2030 (IN $ MILLION)
FIGURE 12: GLOBAL CELL THERAPY MARKET, BY OTHERS, 2022-2030 (IN $ MILLION)
FIGURE 13: GLOBAL CELL THERAPY MARKET, BY NON-STEM CELL, 2022-2030 (IN $ MILLION)
FIGURE 14: GLOBAL CELL THERAPY MARKET, GROWTH POTENTIAL, BY THERAPY TYPE, IN 2021
FIGURE 15: GLOBAL CELL THERAPY MARKET, BY AUTOLOGOUS, 2022-2030 (IN $ MILLION)
FIGURE 16: GLOBAL CELL THERAPY MARKET, BY ALLOGENEIC, 2022-2030 (IN $ MILLION)
FIGURE 17: GLOBAL CELL THERAPY MARKET, GROWTH POTENTIAL, BY THERAPEUTIC APPLICATION, IN 2021
FIGURE 18: GLOBAL CELL THERAPY MARKET, BY MALIGNANCIES, 2022-2030 (IN $ MILLION)
FIGURE 19: GLOBAL CELL THERAPY MARKET, BY MUSCULOSKELETAL DISORDERS, 2022-2030 (IN $ MILLION)
FIGURE 20: GLOBAL CELL THERAPY MARKET, BY AUTOIMMUNE DISORDERS, 2022-2030 (IN $ MILLION)
FIGURE 21: GLOBAL CELL THERAPY MARKET, BY DERMATOLOGY, 2022-2030 (IN $ MILLION)
FIGURE 22: GLOBAL CELL THERAPY MARKET, BY OTHER APPLICATIONS, 2022-2030 (IN $ MILLION)
FIGURE 23: GLOBAL CELL THERAPY MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021
FIGURE 24: GLOBAL CELL THERAPY MARKET, BY HOSPITALS & CLINICS, 2022-2030 (IN $ MILLION)
FIGURE 25: GLOBAL CELL THERAPY MARKET, BY ACADEMIC & RESEARCH INSTITUTES, 2022-2030 (IN $ MILLION)
FIGURE 26: NORTH AMERICA CELL THERAPY MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 27: UNITED STATES CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 28: CANADA CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 29: EUROPE CELL THERAPY MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 30: UNITED KINGDOM CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 31: GERMANY CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 32: FRANCE CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 33: ITALY CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 34: SPAIN CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 35: BELGIUM CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 36: POLAND CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 37: REST OF EUROPE CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 38: ASIA-PACIFIC CELL THERAPY MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 39: CHINA CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 40: JAPAN CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 41: INDIA CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 42: SOUTH KOREA CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 43: THAILAND CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 44: SINGAPORE CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 45: AUSTRALIA & NEW ZEALAND CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 46: REST OF ASIA-PACIFIC CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 47: REST OF WORLD CELL THERAPY MARKET, REGIONAL OUTLOOK, 2021 & 2030 (IN %)
FIGURE 48: LATIN AMERICA CELL THERAPY MARKET, 2022-2030 (IN $ MILLION)
FIGURE 49: MIDDLE EAST & AFRICA CELL THERAPY MARKET, 2022-2030 (IN $ MILLION
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security